Transforming TAVI Practice: Evidence, Equity and Durability

Published: 17 September 2024

  • Views:

    Views Icon 380

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

This video series includes a symposium first presented at ESC 2024 held in London, where Prof Roxana Mehran, Prof Vijay Kunadian, Dr Didier Tchetche, Dr Julia Grapsa and Dr Joanna J Wykrzykowska discuss transforming TAVI practice. The discussion covers topics such as the SMART trial, a comparison of the most commonly used TAVI valves and strategies to address disparities in diagnosing aortic stenosis in women.

 

Please click here to provide feedback on the ESC symposium. 

This video series page is supported by

Learning Objectives

  • Gain insights on the landmark SMART trial, comparing the most used TAVI valves and discuss clinical implications
  • Discover how to address disparities in aortic stenosis diagnosis and treatment of women
  • Interpret the latest data on TAVI valve durability and predictors of valve longevity

Target Audience

  • General Cardiologists
  • Interventional Cardiologists

More from this programme

Part 1

Prof Roxana Mehran Interview

Prof Mehran summarises the key learnings from the scientific session.

1 session
Prof Roxana Mehran Interview Watch now

Part 2

Welcome and Introduction

Welcome and introduction of the presenters and learning objectives by Prof Mehran and Prof Kunadian.

1 session
Welcome and Introduction Watch now

Part 3

SMART Trial Results

Dr Tchétché presents the results of the SMall Annuli Randomized To Evolut or SAPIEN Trial (SMART Trial). The largest, most rigorous trial to date to randomise patients to the two most widely used TAVI devices and the largest TAVI trial to enrol mostly women. It includes a panel discussion on low-flow low gradient aortic stenosis patients and differences in Balloon-Expandable versus Self-Expandable Valves.


 

1 session
SMART Trial Results – A Landmark Head-to-head Randomised Controlled TAVI Trial Watch now

Part 4

Addressing Underdiagnosis in Women With Aortic Stenosis

Dr Grapsa presents the challenge of treating women with aortic stenosis, a common clinical scenario and the differences in clinical presentation between women and men. The session includes how to address underdiagnosis in women including sex specific imaging considerations. The panel discuss early diagnosis, referral of women with aortic stenosis and strategies to adopt to fine tune treatment to a female patient.


 

1 session
Addressing Underdiagnosis in Women With Aortic Stenosis Watch now

Part 5

Durability in TAVI Valves

Dr Wykrzykowska presents durability in TAVI valves, Bioprothetic Valve Dysfunction causes and types. She presents data and long-term follow-up from the Evolut™ TAVI low risk trial, PARTNER 3 trial and NOTION trial and also shares the SMART trial results and predictors. Re-intervention and real world insights from case studies are discussed alongside the panel discussion on valve durability, the need for re-intervention putting into prospective life expectancy and durability of the valve.

1 session
Durability in TAVI Valves – Data, Predictors and Real-world Insights Watch now

Part 6

Take Home Message

Prof Kunadian summarises the scientific session and shares the take home messages.

1 session
Take Home Message Watch now

Faculty Biographies

Vijay Kunadian

Vijay Kunadian

Professor of Interventional Cardiology

Prof Vijay Kunadian is Personal Chair and Professor of Interventional Cardiology at Newcastle University. 

Prof Kunadian completed all her cardiology training in the North East of England. She undertook an international academic fellowship in cardiology at the TIMI/PERFUSE Study group, Brigham and Women’s Hospital/Harvard Medical School, Boston MA.

Prof Kunadian has an international reputation in interventional cardiology and cardiovascular research, making her a sought-after and respected speaker at prominent national and international meetings. She has championed diversity in her specialty as a role model; only 5% of interventional cardiologist are female in the UK, <1% are clinical academics.

 

 

View full profile